{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T13:48:32Z","timestamp":1698414512763},"reference-count":13,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":4618,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[1996,9]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold> We have investigated growth <jats:italic>in vitro<\/jats:italic> of bone marrow megakaryocytic progenitors (CFU\u2010Mk) in 7 patients with paroxysmal nocturnal haemoglobinuria (PNH) to determine the sensitivity of CFU\u2010Mk to complement. Bone marrow light density mononuclear cells were exposed to fresh or heat\u2010inactivated AB human serum in the presence of medium or isotonic sucrose solution. We found that the proliferative activity of bone marrow CFU\u2010Mk in PNH patients was significantly lower than in controls. In addition, the number of CFU\u2010Mk in PNH bone marrow cells exposed to isotonic sucrose and complement was reduced to 25% of that in PNH cells exposed to isotonic sucrose without complement. In conclusion, our finding showed an increased sensitivity of CFU\u2010Mk in PNH bone marrow cells to complement, supporting the hypothesis that the PNH defect is present at the level of CFU\u2010Mk.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1996.tb01368.x","type":"journal-article","created":{"date-parts":[[2010,7,18]],"date-time":"2010-07-18T13:50:22Z","timestamp":1279461022000},"page":"227-229","source":"Crossref","is-referenced-by-count":1,"title":["Megakaryocyte progenitors in paroxysmal nocturnal haemoglobinuria are sensitive to complement"],"prefix":"10.1111","volume":"57","author":[{"given":"Nadezda","family":"Basara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petar","family":"Antunovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dijana","family":"Sefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Radosevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjana","family":"Gotic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"370","volume-title":"Hematology, basic principles and practice","author":"Rosse WF.","year":"1995"},{"key":"e_1_2_1_3_2","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1182\/blood.V75.8.1595.1595","article-title":"Phosphatidyl inositol\u2010linked proteins and paroxysmal nocturnal hemoglobinuria","volume":"75","author":"Rosse WF.","year":"1985","journal-title":"Blood"},{"key":"e_1_2_1_4_2","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1182\/blood.V85.8.2228.bloodjournal8582228","article-title":"Markedly high population of affected reticulocytes negative for decay accelerating factor and CD59 in paroxysmal nocturnal hemoglobinuria","volume":"85","author":"Iwamoto N","year":"1995","journal-title":"Blood"},{"key":"e_1_2_1_5_2","first-page":"222","article-title":"Characterization of the hematopoietic defect in paroxysmal nocturnal hemoglobinuria","volume":"14","author":"Moore JG","year":"1986","journal-title":"Exp Hematol"},{"key":"e_1_2_1_6_2","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1182\/blood.V55.6.1040.1040","article-title":"Complement sensitivity of paroxysmal nocturnal hemoglobinuria bone marrow cells","volume":"55","author":"Tumen J","year":"1980","journal-title":"Blood"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1988.tb02367.x"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0308-2261(21)00464-1"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198504253121704"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.1041130410"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb05153.x"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198309223091202"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/stem.5530020505"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V76.9.1853.1853"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1996.tb01368.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1996.tb01368.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T13:24:57Z","timestamp":1698326697000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1996.tb01368.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,9]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1996,9]]}},"alternative-id":["10.1111\/j.1600-0609.1996.tb01368.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1996.tb01368.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,9]]}}}